Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
|The main aim of the Journal of Molecular Immunology is to publish high quality research works and provide Open Access to the articles using this platform. The Journal offers a rapid and time bound review and publication that freely disseminates research findings related to Molecular Immunology. It caters to the requirements of the medical practitioners, researchers, lab professionals, students, academicians, and industry that are involved in Immunological studies. No matter how prestigious or popular, it increases the visibility and impact of published work. It increases convenience, reach, and retrieval power. Free online literature software facilitates full-text searching, indexing, mining, summarizing, translating, querying, linking, recommending, alerting, "mash-ups" and other forms of processing and analysis.
|Journal of Molecular Immunology brings articles in all areas related to Immuneresponse, Immunoproteomics, Immunoglycomics, Immunogenomics, Cell signaling and activation, Immunoinformatics, Immune systems, Immunogenicity of biopharmaceuticals, Immunotolerance, Immunoglobulins, Immunochemistry, etc..
All works published by OMICS Group are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited. JMI strongly supports the Open Access initiative. All published articles will be assigned DOI provided by Cross Ref. JMI will keep up-to- date the latest advances in the field of Immunology. Abstracts and full texts (HTML, PDF and XML format) of all articles published by JMI are freely accessible to everyone immediately after publication. JMI supports the Bethesda Statement on Open Access Publishing.
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals